FGL1, also known as HFREP1 or hepassocin, was initially identified as an enriched transcript in hepatocellular carcinoma and rodent liver regeneration (Yamamoto et al., 1993; Hara et al., 2001). This evidence concerns the gene FGL1 and hepatocellular carcinoma.